Philippines - English - FDA (Food And Drug Administration)

euro-health care exponents, inc.; importer: n/a; distributor: tgp pharma, inc. - tgp zinc gluconate - syrup (orange flavor) - 10 mg (equivalent to 70 mg zinc gluconate)/5 ml

Philippines - English - FDA (Food And Drug Administration)

health saver pharma inc.; distributor: philgen pharmaceuticals inc. - diclofenac (as sodium) - solution for injection (im/iv) - 25 mg/ml

Philippines - English - FDA (Food And Drug Administration)

health saver pharma inc.; distributor: philgen pharmaceuticals inc. - furosemide - solution for injection (im/iv) - 10mg/ml

Philippines - English - FDA (Food And Drug Administration)

health saver pharma inc.; distributor: philgen pharmaceuticals inc. - cefazolin (as sodium) - powder for injection (im/iv) - 1 g

Philippines - English - FDA (Food And Drug Administration)

health saver pharma inc.; distributor: philgen pharmaceuticals inc. - metoclopramide (as hydrochloride) - solution for injection - 5 mg/ml (10 ml/2 ml)

United States - English - NLM (National Library of Medicine)

fosun pharma usa inc - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for

United States - English - NLM (National Library of Medicine)

dynamic pharmaceuticals inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t) - zinc gluconate 1 [hp_x] - - reduces duration of common cold - reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion

United States - English - NLM (National Library of Medicine)

dynamic pharmaceuticals inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds) - zinc gluconate 1 [hp_x] - reduces duration and severity of the common cold - reduces duration of common cold - reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion

United States - English - NLM (National Library of Medicine)

dynamic pharmaceuticals inc. - zinc acetate (unii: fm5526k07a) (zinc - unii:j41csq7qds), zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds) - zinc acetate 2 [hp_x] - - reduces duration of the common cold - reduces severity of cold symptoms: sore throat, stuffy nose, sneezing, coughing, and congestion

United States - English - NLM (National Library of Medicine)

dynamic pharmaceuticals inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc - unii:j41csq7qds), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), sambucus nigra flower (unii: 07v4dx094t) (sambucus nigra flower - unii:07v4dx094t) - zinc gluconate 1 [hp_x] - - reduces duration of common cold - reduces severity of cold symptoms: stuffy nose, sneezing, sore throat, coughing, and congestion